Group One Trading
ORKA

Group One Trading’s Oruka Therapeutics ORKA Stock Holding History

Group One Trading’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$1.92K – 9377
2025
Q3 		$1.92K Sell
100
-100
-50% -$1.48K ﹤0.01% 7908
2025
Q2 		$2.24K Buy
200
+100
+100% +$1.04K ﹤0.01% 7386
2025
Q1 		$1.03K Buy
+100
New +$1.25K ﹤0.01% 7168
2024
Q4 		– Sell
-6,000
Closed -$147K – 8085
2024
Q3 		$147K Buy
6,000
+5,917
+7,129% +$206K ﹤0.01% 3881
2024
Q2 		$3.83K Buy
+83
New +$3.31K ﹤0.01% 6059
2023
Q4 		– Sell
-8
Closed -$201 – 8325
2023
Q3 		$201 Buy
+8
New +$196 ﹤0.01% 7429
2023
Q1 		– Sell
-1,000
Closed -$28.3K – 8083
2022
Q4 		$28.3K Buy
1,000
+433
+76% +$11.1K ﹤0.01% 5385
2022
Q3 		$14K Buy
+567
New +$16K ﹤0.01% 6311
2022
Q2 		– Sell
-83
Closed -$2K – 8659
2022
Q1 		$2K Buy
83
+41
+98% +$1.02K ﹤0.01% 7764
2021
Q4 		$1K Sell
42
-250
-86% -$7.53K ﹤0.01% 8046
2021
Q3 		$10K Sell
292
-33
-10% -$1.22K ﹤0.01% 7514
2021
Q2 		$14K Sell
325
-933
-74% -$38.9K ﹤0.01% 7388
2021
Q1 		$55K Buy
+1,258
New +$66K ﹤0.01% 6156

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Group One Trading's ORKA Position: Q1 2026 in Review

Group One Trading held its Oruka Therapeutics (ORKA) position steady in Q1 2026 at 200 shares worth $9.81K. The position accounts for ﹤0.01% of the portfolio, ranked #6387.

Group One Trading first reported a position in ORKA in Q1 2021 and has held it in 10 quarters since. The position peaked at $327K in Q2 2022. 184 funds tracked by Wall St. Rank hold ORKA as of Q1 2026.

  • Group One Trading held 200 shares of Oruka Therapeutics worth $9.81K as of Q1 2026.
  • Group One Trading left its Oruka Therapeutics share count unchanged in Q1 2026.
  • Oruka Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6387 holding.
  • Group One Trading first reported a position in Oruka Therapeutics in Q1 2021 and has held it in 10 quarters since.
  • Group One Trading's Oruka Therapeutics position peaked at $327K in Q2 2022.
  • 184 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.